Kemp Dolliver
Stock Analyst at Brookline Capital Markets
(1.56)
# 3,587
Out of 4,689 analysts
66
Total ratings
33.3%
Success rate
0.1%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Downgraded: Hold | $100 → $105 | $100.77 | +4.20% | 2 | Jul 28, 2026 | |
| LSTA Lisata Therapeutics | Downgraded: Hold | n/a | $1.69 | - | 3 | Jul 27, 2026 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Initiated Coverage: Buy | $1.54 | $0.29 | +440.35% | 1 | Jul 13, 2026 | |
| CLRB Cellectar Biosciences | Initiated Coverage: Buy | $15 | $2.53 | +492.89% | 1 | Jul 12, 2026 | |
| ICCM IceCure Medical | Maintained: Buy | $83 → $74 | $2.30 | +3,095.65% | 7 | Jun 17, 2026 | |
| RNTX Rein Therapeutics | Downgraded: Hold | n/a | $0.7621 | - | 4 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgraded: Buy | $17 | $5.69 | +198.77% | 4 | Dec 17, 2025 | |
| MNPR Monopar Therapeutics | Maintained: Buy | $52 → $93 | $111.89 | -16.88% | 2 | Sep 25, 2025 | |
| IBIO iBio, Inc. | Reiterated: Buy | $1.6 | $1.36 | +17.65% | 3 | Sep 5, 2025 | |
| BIOX Bioceres Crop Solutions | Downgraded: Hold | $24 → $26 | $0.41 | n/a | 8 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $11 | $0.735 | n/a | 4 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $2.41 | n/a | 1 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $13.07 | n/a | 1 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $3.11 | n/a | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.26 | n/a | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $150 → $26 | $5.60 | n/a | 2 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $31 | $0.6449 | n/a | 2 | Jan 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.86 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.095 | n/a | 1 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $25 → $30 | $2.66 | n/a | 2 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $4.5 | $0.0003 | n/a | 6 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 → $23 | $9.63 | n/a | 3 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.001 | n/a | 1 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.62 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8 | $5.39 | n/a | 1 | Oct 20, 2022 |
Lantheus Holdings
Jul 28, 2026
Downgraded: Hold
Price Target: $100 → $105
Current: $100.77
Upside: +4.20%
Lisata Therapeutics
Jul 27, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.69
Upside: -
Perimeter Medical Imaging AI, Inc.
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $1.54
Current: $0.29
Upside: +440.35%
Cellectar Biosciences
Jul 12, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $2.53
Upside: +492.89%
IceCure Medical
Jun 17, 2026
Maintained: Buy
Price Target: $83 → $74
Current: $2.30
Upside: +3,095.65%
Rein Therapeutics
Jan 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.7621
Upside: -
Verrica Pharmaceuticals
Dec 17, 2025
Upgraded: Buy
Price Target: $17
Current: $5.69
Upside: +198.77%
Monopar Therapeutics
Sep 25, 2025
Maintained: Buy
Price Target: $52 → $93
Current: $111.89
Upside: -16.88%
iBio, Inc.
Sep 5, 2025
Reiterated: Buy
Price Target: $1.6
Current: $1.36
Upside: +17.65%
Bioceres Crop Solutions
Aug 22, 2025
Downgraded: Hold
Price Target: $24 → $26
Current: $0.41
Upside: n/a
Aug 18, 2025
Maintained: Buy
Price Target: $36 → $11
Current: $0.735
Upside: n/a
Jul 21, 2025
Initiated Coverage: Buy
Price Target: $18
Current: $2.41
Upside: n/a
Jul 9, 2025
Initiated Coverage: Buy
Price Target: $25
Current: $13.07
Upside: n/a
Mar 10, 2025
Initiated Coverage: Buy
Price Target: $11
Current: $3.11
Upside: n/a
Nov 15, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.26
Upside: n/a
Feb 14, 2024
Maintained: Buy
Price Target: $150 → $26
Current: $5.60
Upside: n/a
Jan 24, 2024
Upgraded: Buy
Price Target: $31
Current: $0.6449
Upside: n/a
Dec 19, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.86
Upside: n/a
Dec 7, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.095
Upside: n/a
Oct 31, 2023
Upgraded: Buy
Price Target: $25 → $30
Current: $2.66
Upside: n/a
Sep 5, 2023
Downgraded: Hold
Price Target: $7 → $4.5
Current: $0.0003
Upside: n/a
Jul 11, 2023
Initiated Coverage: Buy
Price Target: $19 → $23
Current: $9.63
Upside: n/a
May 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
May 1, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Jan 6, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Dec 16, 2022
Reiterated: Buy
Price Target: $13
Current: $4.62
Upside: n/a
Oct 20, 2022
Initiated Coverage: Buy
Price Target: $8
Current: $5.39
Upside: n/a